Prognostic factors in lymphomas: the contribution of immunophenotyping and molecular studies
- 31 December 1990
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 2 (5) , 719-722
- https://doi.org/10.1016/0952-7915(90)90037-h
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1989
- Leu-8/TQ1 is the human equivalent of the Mel-14 lymph node homing receptorNature, 1989
- Risk classification as the basis for clinical staging of diffuse large- cell lymphoma derived from 10-year survival dataBlood, 1989
- bcl-2and Other Genomic Alterations in the Prognosis of Large-Cell LymphomaNew England Journal of Medicine, 1989
- AIDS-associated non-Hodgkin's lymphoma in San FranciscoPublished by American Medical Association (AMA) ,1989
- The Non-Hodgkin Lymphoma Pathologic Classification ProjectAnnals of Internal Medicine, 1988
- The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotypeBlood, 1988
- Circulating malignant cells in non-Hodgkin's lymphoma: correlation with binding by peanut agglutininBlood, 1988
- Intermediate lymphocytic lymphoma: An immunophenotypic study with comparison to small lymphocytic lymphoma and diffuse small cleaved cell lymphomaHuman Pathology, 1988
- Immunophenotyping of hematopoieticmalignancies in paraffin sectionsHuman Pathology, 1988